RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
P110 Lenalidomide in low and int-1 risk MDS with del5q: efficacy and quality of life
2009-01-01 Poloni, A
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression
2006-01-01 Olivieri, Attilio; SVEGLIATI BARONI, Silvia; Bacigalupo, A; Campelli, N; Piaggio, S; Luchetti, MICHELE MARIA; Trappolini, S; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando
Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients
2013-01-01 Olivieri, Attilio; Capelli, D; Attolico, I; Pascale, S; Nuccorini, R; Coluzzi, S; Pizzuti, M; Saraceni, F; Chiarucci, M; Bartocci, C; Viola, N; Mancini, Stefania; Scortechini, Ar; Serrani, Federica; Poloni, Antonella; Leoni, Pietro
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography
2014-01-01 Gini, Guido; Olivieri, Jacopo; Bocci, Caterina; Sampaolo, Michela; Trappolini, Silvia; Olivieri, Attilio; Offidani, Massimo; Rupoli, Serena; Poloni, Antonella; Scortechini, Anna Rita; Capelli, Debora; Montanari, Mauro; Scortechini, Ilaria; Perna, Gian Piero; Leoni, Pietro
Prognostic Factors of Response to Erythropoiesis Stimulating Agents (ESA) Treatment in Non RBC Transfusion Dependent Lower Risk MDS. Preliminary Results of a French and Italian Study (on behalf of the GFM and FISM)
2012-01-01 Park, Sophie; Zini, Gina; Andrieu, Valérie; Levis, Alessandro; Gioia, Daniela; Duchayne, Eliane; Poloni, Antonella; Balleari, Enrico; Calabrese, Marco; Sudaka, Isabelle; Siguret, Virginie; Guesnu, Martine; Kosmider, Olivier; Fontenay, Michaela; Sanna, Alessandro; Lemaire, Pierre; Beyne Rauzy, Odile; Ades, Lionel; Legros, Laurence; Danise, Paolo; Musto, Pellegrino; Fenaux, Pierre; Dreyfus, Francois; Santini, Valeria
Prognostic factors of response to erytropoiesis stimulating agents (ESA) Treatment in non RBC transfusion dependent lower risk MDS. Preliminary results of a french and italian study (on behalf of the GFM and FISM)
2012-01-01 Park, S; Zini, G; Andrieu, V; Levis, A; Gioia, D; Duchayna, E; Poloni, Antonella; Balleari, E; Calabrese, M; Sudaka, I; Siguret, V; Guesnu, M; Kosmider, O; Fontenay, M; Sanna, A; Lemaire, P; Beyne Rauzy, O; Ades, L; Legros, L; Danise, P; Musto, P; Fenaux, P; Dreyfus, F; Santini, V.
QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL
2015-01-01 E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22
Randomised Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial
2019-01-01 Poloni, A
Real life experience: high dose cytarabine feasibility and efficacy in an elderly cohort of 149 AML patients evaluated with multidimensional geriatric assessment
2013-01-01 Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Offidani, M; Trappolini, S; Montanari, M; Rupoli, S; Scortechini, A; Gini, G; Scortechini, I; Discepoli, G; Leoni, Pietro; Olivieri, Attilio
Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation
2003-01-01 Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| P110 Lenalidomide in low and int-1 risk MDS with del5q: efficacy and quality of life | 1-gen-2009 | Poloni, A | |
| Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression | 1-gen-2006 | Olivieri, Attilio; SVEGLIATI BARONI, Silvia; Bacigalupo, A; Campelli, N; Piaggio, S; Luchetti, MICHELE MARIA; Trappolini, S; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando | |
| Predictive value of post-induction and post-consolidation MRD: a comparison of multiparameter flow cytometry and WT1 RT-PCR techniques in 75 acute myeloid leukemia (AML) patients | 1-gen-2013 | Olivieri, Attilio; Capelli, D; Attolico, I; Pascale, S; Nuccorini, R; Coluzzi, S; Pizzuti, M; Saraceni, F; Chiarucci, M; Bartocci, C; Viola, N; Mancini, Stefania; Scortechini, Ar; Serrani, Federica; Poloni, Antonella; Leoni, Pietro | |
| Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography | 1-gen-2014 | Gini, Guido; Olivieri, Jacopo; Bocci, Caterina; Sampaolo, Michela; Trappolini, Silvia; Olivieri, Attilio; Offidani, Massimo; Rupoli, Serena; Poloni, Antonella; Scortechini, Anna Rita; Capelli, Debora; Montanari, Mauro; Scortechini, Ilaria; Perna, Gian Piero; Leoni, Pietro | |
| Prognostic Factors of Response to Erythropoiesis Stimulating Agents (ESA) Treatment in Non RBC Transfusion Dependent Lower Risk MDS. Preliminary Results of a French and Italian Study (on behalf of the GFM and FISM) | 1-gen-2012 | Park, Sophie; Zini, Gina; Andrieu, Valérie; Levis, Alessandro; Gioia, Daniela; Duchayne, Eliane; Poloni, Antonella; Balleari, Enrico; Calabrese, Marco; Sudaka, Isabelle; Siguret, Virginie; Guesnu, Martine; Kosmider, Olivier; Fontenay, Michaela; Sanna, Alessandro; Lemaire, Pierre; Beyne Rauzy, Odile; Ades, Lionel; Legros, Laurence; Danise, Paolo; Musto, Pellegrino; Fenaux, Pierre; Dreyfus, Francois; Santini, Valeria | |
| Prognostic factors of response to erytropoiesis stimulating agents (ESA) Treatment in non RBC transfusion dependent lower risk MDS. Preliminary results of a french and italian study (on behalf of the GFM and FISM) | 1-gen-2012 | Park, S; Zini, G; Andrieu, V; Levis, A; Gioia, D; Duchayna, E; Poloni, Antonella; Balleari, E; Calabrese, M; Sudaka, I; Siguret, V; Guesnu, M; Kosmider, O; Fontenay, M; Sanna, A; Lemaire, P; Beyne Rauzy, O; Ades, L; Legros, L; Danise, P; Musto, P; Fenaux, P; Dreyfus, F; Santini, V. | |
| QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBOCONTROLLED PROSPECTIVE TRIAL | 1-gen-2015 | E. N., Oliva1; * V., Santini2; C., Alati1; G., Sanpaolo3; Poloni, Antonella; A., Molteni5; F., Ronco1; G., Palumbo6; A., Marino1; S., Impera7; E., Balleari8; P., Salutari9; P., Cufari1; I., Santacaterina1; P., Avanzini10; P., Niscola11; A. M., Liberati12; A., Ricco13; F., Morabito14; A., Cortelezzi15; L., Fianchi16; F., Buccisano17; P., Fenaux18; O., Beyne Rauzy19; F., Rodeghiero20; F., Salvi21; R., Latagliata22 | |
| Randomised Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial | 1-gen-2019 | Poloni, A | |
| Real life experience: high dose cytarabine feasibility and efficacy in an elderly cohort of 149 AML patients evaluated with multidimensional geriatric assessment | 1-gen-2013 | Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Offidani, M; Trappolini, S; Montanari, M; Rupoli, S; Scortechini, A; Gini, G; Scortechini, I; Discepoli, G; Leoni, Pietro; Olivieri, Attilio | |
| Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation | 1-gen-2003 | Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 79
- 1 Contributo su Rivista::1.5 Abst... 79
Data di pubblicazione
- 2020 - 2022 2
- 2010 - 2019 58
- 2002 - 2009 19
Rivista
- BLOOD 32
- HAEMATOLOGICA 17
- BONE MARROW TRANSPLANTATION 10
- HAEMATOLOGICA 10
- LEUKEMIA RESEARCH 6
- BIOCHIMICA CLINICA 1
- BLOOD 1
- PSYCHO-ONCOLOGY 1
- REVISTA BRASILEIRA DE HEMATOLOGIA... 1
Lingua
- eng 45
Accesso al fulltext
- no fulltext 79